What are the potential side effects and long-term effects of Levetiracetam (Keppra) in a 2-year-old girl?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Side Effects of Levetiracetam (Keppra) in a 2-Year-Old Girl

For a 2-year-old girl prescribed levetiracetam (Keppra) for 3 weeks, the most common side effects include somnolence, irritability, behavioral changes, and dizziness, while long-term effects are generally minimal when used short-term.

Common Short-Term Side Effects

Levetiracetam (Keppra) can cause several side effects in young children, with the most frequently reported ones being:

  • Neurological effects:

    • Somnolence (drowsiness)
    • Dizziness
    • Fatigue
  • Behavioral effects:

    • Irritability
    • Hostility
    • Nervousness
    • Emotional lability (mood swings)
  • Other common effects:

    • Decreased appetite
    • Nasopharyngitis (common cold symptoms)
    • Headache

According to FDA drug information, the most common adverse events in pediatric patients include somnolence, accidental injury, hostility, nervousness, and asthenia (weakness) 1.

Less Common Side Effects

Less frequently reported side effects include:

  • Gastrointestinal issues (nausea, vomiting)
  • Cough
  • Rash
  • Coordination difficulties (ataxia)
  • Tremor

Behavioral Side Effects

Behavioral side effects deserve special attention as they are more common in pediatric patients:

  • Irritability and moodiness
  • Hyperactive behavior
  • Hostility
  • In rare cases, more severe behavioral changes 2

One study reported that behavioral side effects occurred in approximately 26.9% of pediatric patients, with severe behavioral effects (psychosis, confusion) in about 6.4% 3.

Long-Term Effects

For a 3-week course of treatment:

  • Minimal long-term concerns: The short duration of therapy (3 weeks) significantly reduces the risk of long-term effects.
  • Reversibility: Most side effects resolve completely after discontinuation of the medication.

The half-life of levetiracetam in children is approximately 5 hours 4, which means the drug will be eliminated from the body within a few days after stopping treatment.

Monitoring Recommendations

During the 3-week treatment period, parents should monitor for:

  1. Changes in behavior or mood
  2. Excessive drowsiness that interferes with daily activities
  3. Any signs of allergic reaction (rare)
  4. Changes in eating patterns

What to Expect After Discontinuation

After completing the 3-week course:

  • Most side effects typically resolve within 24-72 hours
  • No tapering is usually required for short-term therapy
  • No long-term neurological or developmental effects have been documented from short-term use

When to Seek Medical Attention

Parents should contact their healthcare provider immediately if the child experiences:

  • Severe behavioral changes
  • Prolonged or severe drowsiness
  • Any signs of allergic reaction
  • Unusual movements or seizures

Bottom Line

For a 2-year-old taking levetiracetam for only 3 weeks, the risk of serious or long-lasting side effects is low. Most children tolerate the medication well, and any side effects that do occur typically resolve quickly after the medication is discontinued. The benefits of seizure control generally outweigh the risks of short-term side effects for most children.

References

Research

Levetiracetam in children, adolescents and young adults with intractable epilepsy: efficacy, tolerability and effect on electroencephalogram--a pilot study.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society, 2013

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.